Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells
Open Access
- 12 December 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Experimental & Clinical Cancer Research
- Vol. 37 (1), 311
- https://doi.org/10.1186/s13046-018-0975-0
Abstract
Aldehyde dehydrogenase 1A1 (ALDH1A1), a member of aldehyde dehydrogenase family, is a marker of stemness in breast cancer. During tumor progression cancer stem cells (CSCs) have been reported to secrete angiogenic factors to orchestrate the formation of pathological angiogenesis. This vasculature can represent the source of self-renewal of CSCs and the route for further tumor spreading. The aim of the present study has been to assess whether ALDH1A1 controls the output of angiogenic factors in breast cancer cells and regulates tumor angiogenesis in a panel of in vitro and in vivo models. Stemness status of breast cancer cells was evaluated by the ability to form turmorspheres in vitro. A transwell system was used to assess the angiogenic features of human umbilical vein endothelial cells (HUVEC) when co-cultured with breast cancer cells MCF-7 harboring different levels of ALDH1A1. Under these conditions, we survey endothelial proliferation, migration, tube formation and permeability. Moreover, in vivo, MCF-7 xenografts in immunodeficient mice allow to evaluate blood flow, expression of angiogenic factors and microvascular density (MVD). In MCF-7 we observed that ALDH1A1 activity conferred stemness property and its expression correlated with an activation of angiogenic factors. In particular we observed a significant upregulation of hypoxia inducible factor-1α (HIF-1α) and proangiogenic factors, such as vascular endothelial growth factor (VEGF). High levels of ALDH1A1, through the retinoic acid pathway, were significantly associated with VEGF-mediated angiogenesis in vitro. Co-culture of HUVEC with ALDH1A1 expressing tumor cells promoted endothelial proliferation, migration, tube formation and permeability. Conversely, downregulation of ALDH1A1 in MCF-7 resulted in reduction of proangiogenic factor release/expression and impaired HUVEC angiogenic functions. In vivo, when subcutaneously implanted in immunodeficient mice, ALDH1A1 overexpressing breast tumor cells displayed a higher expression of VEGF and MVD. In breast tumors, ALDH1A1 expression primes a permissive microenvironment by promoting tumor angiogenesis via retinoic acid dependent mechanism. In conclusion, ALDH1A1 might be associated to progression and diffusion of breast cancer.Keywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro (IG10731)
- Ministero dell’Istruzione, dell’Università e della Ricerca (2015Y3C5KP)
This publication has 38 references indexed in Scilit:
- Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not?Nature Reviews Clinical Oncology, 2011
- Inhibition of Hypoxia Inducible Factor-1α by Dihydroxyphenylethanol, a Product from Olive Oil, Blocks Microsomal Prostaglandin-E Synthase-1/Vascular Endothelial Growth Factor Expression and Reduces Tumor AngiogenesisClinical Cancer Research, 2010
- Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast CancerClinical Cancer Research, 2010
- Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cellsBritish Journal of Cancer, 2007
- Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesisBritish Journal of Cancer, 2007
- Transcriptional regulation of the Vascular Endothelial Growth Factor gene?a concert of activating factorsCardiovascular Research, 2005
- Association between histology grade, expression of HsMCM2, and cyclin A in human invasive breast carcinomasJournal of Clinical Pathology, 2003
- Microvessel density and vessel invasion in lymph‐node‐negative breast cancer: Effect on recurrence‐free survivalInternational Journal of Cancer, 1995
- Multiplicity generates diversity in the retinoic acid signalling pathwaysTrends in Biochemical Sciences, 1992
- Tumor Angiogenesis: Therapeutic ImplicationsThe New England Journal of Medicine, 1971